Analysts have provided the following ratings for Scotts Miracle Gro SMG within the last quarter:
Last 30 Days | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|
Bullish | 1 | 2 | 1 | 0 |
Somewhat Bullish | 0 | 0 | 0 | 0 |
Indifferent | 0 | 0 | 0 | 0 |
Somewhat Bearish | 0 | 0 | 0 | 0 |
Bearish | 0 | 0 | 0 | 0 |
5 analysts offering 12-month price targets in the last 3 months for Scotts Miracle Gro evaluate the company at an average price target of $266.0 with a high of $305.00 and a low of $225.00.
This current average has decreased by 10.96% from the previous average price target of $298.75.
How Are Analyst Ratings Determined?
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may suggest actions like "buy", "sell", "hold", or similar verbage for each stock based on research compiled from the corresponding company. Analysts who suggest "buy" are telling traders to purchase the stock based on forecasted growth. On the flip side, analysts who suggest "sell" are telling traders to dump the stock because of a similarly forecasted decline. Analysts who suggest "hold" are telling investors that they see short-term or mid-term stagnation and to maintain their positions on the stock.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.